University of Virginia Study Reveals Promising Method for Reducing MRSA Infections in Hospital Intensive Care UnitsSeptember 05, 2008Doctors at the University of Virginia Health System have significantly reduced MRSA infections among surgical intensive care patients by using antibiotic cycling, a method of rotating drugs at regular intervals. In a study published in the September 3, 2008 issue of Surgical Infections, UVA researchers report that switching between two antibiotics, linezolid and vancomycin, every three months in the surgical ICU decreased the MRSA infection rate from 1.9 to 1.4 patients per 100 admissions. In-hospital mortality from surgical ICU-acquired MRSA infections fell from 3.8 patients per year to none. Study data spanned six years, including the period before cycling began (1997 to 2001) and the period after it was instituted (2002 to 2003). The study's key focus was resistant gram-positive cocci, a subgroup defined as MRSA (which stands for methicillin-resistant Staphylococcus aureus) and VRE (which is an acronym for vancomycin-resistant Enterococcus).
"Before we began cycling, 67 percent of the Staphylococcus aureus infections in our surgical ICU were caused by MRSA," notes the study's lead author, Dr. Robert Sawyer, a professor of surgery and co-director of UVA's Surgical Trauma Intensive Care Unit. "Cycling reduced MRSA cases to 36 percent of that total." The UVA study is the first to assess the impact of antibiotic cycling on a group of bacteria known as gram-positive cocci. Increasingly problematic in hospitals, these pathogens tend to develop resistance to antibiotics in sterile and contained environments - areas like ICUs - where patients have weakened immune systems due to severe illness, open wounds, surgical incisions, catheters or other implanted medical devices. At UVA, surgical ICU patients include those who are recovering from trauma, organ transplants or invasive procedures. According to Dr. Sawyer, UVA's findings are important, yet need to be confirmed by similar studies in other ICU's. "If cycling proves effective at other centers, we might be able to turn the tide on antibiotic resistance, at least for MRSA. In the long run, reducing MRSA should decrease the number of deaths among critically ill patients," he notes. "However, the problem is very complex and will almost certainly need a variety of interventions to achieve the best outcomes." While MRSA infection rates fell during cycling, the prevalence of VRE remained virtually unaltered. VRE infection rates rose slightly, from .76 to .98 patients per 100 admissions. In-hospital mortality from VRE dropped from 2.8 to 2.5 patients per year. Cycling reduced the surgical ICU's overall gram-positive infection rate from 19.6 to 11.8 patients per 100 admissions. It lowered the rate of infections from resistant gram-positive cocci from 4.6 to 1.7 patients per 100 admissions. University of Virginia | |||||||||||||||||||||
|
Related Mrsa Current Events and Mrsa News Articles Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. Rhode Island Hospital study finds local retail meat safe from antibiotic-resistant organisms Rhode Island Hospital researchers report that findings from a new study of retail meat in the Providence, RI area indicate little to no presence of antibiotic-resistant bacteria. Researchers downplay MRSA screening as effective infection control intervention Three Virginia Commonwealth University epidemiologists are downplaying the value of mandatory universal nasal screening of patients for MRSA, arguing that proven, hospital-wide infection control practices can prevent more of the potentially fatal infections. Nanotechnology boosts war on superbugs This week Nature Nanotechnology journal (October 12th) reveals how scientists from the London Centre for Nanotechnology (LCN) at UCL are using a novel nanomechanical approach to investigate the workings of vancomycin, one of the few antibiotics that can be used to combat increasingly resistant infections such as MRSA. Is re-emerging superbug the next MRSA? Loyola physicians warn little-known bacteria Clostridium difficile next emerging disease threat, killing 1,000s in the United State. 'Superbug' breast infections controllable in nursing mothers, researchers find Many nursing mothers who have been hospitalized for breast abscesses are afflicted with the "superbug" methicillin-resistant Staphylococcus aureus, or MRSA, but according to new research by UT Southwestern Medical Center physicians, conservative treatment can deal with the problem. Nature inspires new highly specific drugs and organic products The best place to seek novel compounds for pharmaceutical drugs, alternative energy sources, and a host of industrial applications, is within natural systems that have evolved over millions of years. Chips are down as Manchester makes protein scanning breakthrough Scientists at The University of Manchester have developed a new and fast method for making biological 'chips' - technology that could lead to quick testing for serious diseases, fast detection of MRSA infections and rapid discovery of new drugs. Researchers analyze how new anti-MRSA abtibiotics function A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA. European league-tables for antibiotic resistance revealed Tests of antibiotic resistance in cattle have revealed stark variation across thirteen European countries. The results, published today in BioMed Central's open-access journal Acta Veterinaria Scandinavica, show that major differences were apparent in the occurrence of resistance between countries and between the different antimicrobial agents tested. More Mrsa Current Events and Mrsa News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||